Humacyte Inc (NAS:HUMA)
$ 0.71 -0.0063 (-0.9%) Market Cap: 190.80 Mil Enterprise Value: 208.16 Mil PE Ratio: 0 PB Ratio: 13.61 GF Score: 23/100

Q4 2024 Humacyte Inc Earnings Call Transcript

Mar 28, 2025 / 12:30PM GMT
Release Date Price: $1.96 (-2.49%)
Operator

Good morning, ladies and gentlemen, and welcome to the Humacyte fourth quarter results conference call. (Operator Instructions) As a reminder, this conference call is being recorded. I'll now turn the call over to Tom Johnson with LifeSci Advisors. Please go ahead, sir.

Tom Johnson
LifeSci Advisors, LLC - Analyst

Thank you, operator. Before we proceed with today's call, I would like to remind everyone that certain statements made during the call are forward-looking statements under US federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call are contained in our periodic reports filed with the SEC.

The forward-looking statements made during this call speak only as the date hereof, and the company undertakes no obligation to update or revise forward-looking statements, except required by law. Information

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot